BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 10913155)

  • 1. Sustained down-regulation of the epidermal growth factor receptor by decorin. A mechanism for controlling tumor growth in vivo.
    Csordás G; Santra M; Reed CC; Eichstetter I; McQuillan DJ; Gross D; Nugent MA; Hajnóczky G; Iozzo RV
    J Biol Chem; 2000 Oct; 275(42):32879-87. PubMed ID: 10913155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells.
    Santra M; Eichstetter I; Iozzo RV
    J Biol Chem; 2000 Nov; 275(45):35153-61. PubMed ID: 10942781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decorin protein core inhibits in vivo cancer growth and metabolism by hindering epidermal growth factor receptor function and triggering apoptosis via caspase-3 activation.
    Seidler DG; Goldoni S; Agnew C; Cardi C; Thakur ML; Owens RT; McQuillan DJ; Iozzo RV
    J Biol Chem; 2006 Sep; 281(36):26408-18. PubMed ID: 16835231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decorin activates the epidermal growth factor receptor and elevates cytosolic Ca2+ in A431 carcinoma cells.
    Patel S; Santra M; McQuillan DJ; Iozzo RV; Thomas AP
    J Biol Chem; 1998 Feb; 273(6):3121-4. PubMed ID: 9452417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decorin binds to a narrow region of the epidermal growth factor (EGF) receptor, partially overlapping but distinct from the EGF-binding epitope.
    Santra M; Reed CC; Iozzo RV
    J Biol Chem; 2002 Sep; 277(38):35671-81. PubMed ID: 12105206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decorin suppresses prostate tumor growth through inhibition of epidermal growth factor and androgen receptor pathways.
    Hu Y; Sun H; Owens RT; Wu J; Chen YQ; Berquin IM; Perry D; O'Flaherty JT; Edwards IJ
    Neoplasia; 2009 Oct; 11(10):1042-53. PubMed ID: 19794963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor.
    Moscatello DK; Santra M; Mann DM; McQuillan DJ; Wong AJ; Iozzo RV
    J Clin Invest; 1998 Jan; 101(2):406-12. PubMed ID: 9435313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decorin is a biological ligand for the epidermal growth factor receptor.
    Iozzo RV; Moscatello DK; McQuillan DJ; Eichstetter I
    J Biol Chem; 1999 Feb; 274(8):4489-92. PubMed ID: 9988678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decorin antagonizes corneal fibroblast migration via caveolae-mediated endocytosis of epidermal growth factor receptor.
    Mohan RR; Tripathi R; Sharma A; Sinha PR; Giuliano EA; Hesemann NP; Chaurasia SS
    Exp Eye Res; 2019 Mar; 180():200-207. PubMed ID: 30611736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.
    Ständer M; Naumann U; Wick W; Weller M
    Cell Tissue Res; 1999 May; 296(2):221-7. PubMed ID: 10382266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for decorin in the structural organization of periodontal ligament.
    Häkkinen L; Strassburger S; Kähäri VM; Scott PG; Eichstetter I; Lozzo RV; Larjava H
    Lab Invest; 2000 Dec; 80(12):1869-80. PubMed ID: 11140699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases.
    Santra M; Mann DM; Mercer EW; Skorski T; Calabretta B; Iozzo RV
    J Clin Invest; 1997 Jul; 100(1):149-57. PubMed ID: 9202067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inactivity of TGF-beta/decorin complexes.
    Hausser H; Gröning A; Hasilik A; Schönherr E; Kresse H
    FEBS Lett; 1994 Oct; 353(3):243-5. PubMed ID: 7957866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis.
    Zhu JX; Goldoni S; Bix G; Owens RT; McQuillan DJ; Reed CC; Iozzo RV
    J Biol Chem; 2005 Sep; 280(37):32468-79. PubMed ID: 15994311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative regulation of transforming growth factor-beta by the proteoglycan decorin.
    Yamaguchi Y; Mann DM; Ruoslahti E
    Nature; 1990 Jul; 346(6281):281-4. PubMed ID: 2374594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin suppresses transforming growth factor-beta-induced expression of plasminogen activator inhibitor-1 in human mesangial cells through a mechanism that involves Ca2+-dependent phosphorylation of Smad2 at serine-240.
    Abdel-Wahab N; Wicks SJ; Mason RM; Chantry A
    Biochem J; 2002 Mar; 362(Pt 3):643-9. PubMed ID: 11879191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of extracellular signal-regulated protein kinase1,2 results in down-regulation of decorin expression in fibroblasts.
    Laine P; Reunanen N; Ravanti L; Foschi M; Santra M; Iozzo RV; Kähäri VM
    Biochem J; 2000 Jul; 349(Pt 1):19-25. PubMed ID: 10861206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decorin suppresses tumor cell-mediated angiogenesis.
    Grant DS; Yenisey C; Rose RW; Tootell M; Santra M; Iozzo RV
    Oncogene; 2002 Jul; 21(31):4765-77. PubMed ID: 12101415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The action of decorin in anti-fibrosis and anti-cancer].
    Ma W; Tan Y; Cai S; Chen H; Du J; Cai S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):222-5. PubMed ID: 17333927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of up-regulation of Decorin on expression of EGFR, C-Myc and p21 in nude mice with oral squamous cell carcinoma].
    Guo MY; Li KY; Nie MH; Liu XQ
    Shanghai Kou Qiang Yi Xue; 2023 Feb; 32(1):40-46. PubMed ID: 36973842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.